119 related articles for article (PubMed ID: 30038597)
1. Long Non-coding Antisense RNA TNRC6C-AS1 Is Activated in Papillary Thyroid Cancer and Promotes Cancer Progression by Suppressing TNRC6C Expression.
Muhanhali D; Zhai T; Jiang J; Ai Z; Zhu W; Ling Y
Front Endocrinol (Lausanne); 2018; 9():360. PubMed ID: 30038597
[No Abstract] [Full Text] [Related]
2. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O
Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479
[TBL] [Abstract][Full Text] [Related]
3. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer.
Qin Y; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang W; Wu C
Endocrine; 2018 Mar; 59(3):555-564. PubMed ID: 29327301
[TBL] [Abstract][Full Text] [Related]
4. TNRC6C Functions as a Tumor Suppressor and Is Frequently Downregulated in Papillary Thyroid Cancer.
Cai Z; Zhai T; Muhanhali D; Ling Y
Int J Endocrinol; 2021; 2021():6686998. PubMed ID: 33564303
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.
Peng X; Ji C; Tan L; Lin S; Zhu Y; Long M; Luo D; Li H
J Cell Mol Med; 2020 Jan; 24(1):304-316. PubMed ID: 31657132
[TBL] [Abstract][Full Text] [Related]
6. Suppression of long non-coding RNA TNRC6C-AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway.
Yang LX; Wu J; Guo ML; Zhang Y; Ma SG
Cell Prolif; 2019 May; 52(3):e12564. PubMed ID: 30938030
[TBL] [Abstract][Full Text] [Related]
7. TNRC6C-AS1 Promotes Thyroid Cancer Progression by Upregulating LPAR5 via miR-513c-5p.
Tong C; Wang C; Wang Y; Xiao X
Cancer Manag Res; 2021; 13():6141-6155. PubMed ID: 34393509
[TBL] [Abstract][Full Text] [Related]
8. SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis.
Xin Y; Shang X; Sun X; Xu G; Liu Y; Liu Y
Bioengineered; 2022 May; 13(5):12572-12582. PubMed ID: 35599603
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the long non-coding RNA FOXD2-AS1 is correlated with tumor progression and metastasis in papillary thyroid cancer.
Li H; Han Q; Chen Y; Chen X; Ma R; Chang Q; Yin D
Am J Transl Res; 2019; 11(9):5457-5471. PubMed ID: 31632522
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of lncRNA SLC26A4-AS1 inhibits papillary thyroid carcinoma progression through recruiting ETS1 to promote ITPR1-mediated autophagy.
Peng D; Li W; Zhang B; Liu X
J Cell Mol Med; 2021 Sep; 25(17):8148-8158. PubMed ID: 34378314
[TBL] [Abstract][Full Text] [Related]
11. FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway.
Luo X; Gao Q; Zhou T; Tang R; Zhao Y; Zhang Q; Wang N; Ye H; Chen X; Chen S; Tang W; Zhao D
Front Oncol; 2022; 12():900836. PubMed ID: 35720005
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA ILF3-AS1 aggravates papillary thyroid carcinoma progression via regulating the miR-4306/PLAGL2 axis.
Zeng Z; Teng Q; Xiao J
Cancer Cell Int; 2021 Jun; 21(1):322. PubMed ID: 34176471
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
14. The Long Non-Coding RNA ENST00000489676 Influences Papillary Thyroid Cancer Cell Proliferation and Invasion through Regulating MiR-922.
Wang W; Xia S; Zhan W
J Cancer; 2019; 10(22):5434-5446. PubMed ID: 31632488
[No Abstract] [Full Text] [Related]
15. Long non-coding RNA
Shao L; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Qin Y
Aging (Albany NY); 2020 Sep; 12(18):18019-18032. PubMed ID: 32960785
[TBL] [Abstract][Full Text] [Related]
16. Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo.
Wang Q; Yang L; Hu X; Jiang Y; Hu Y; Liu Z; Liu J; Wen T; Ma Y; An G; Feng G
Oncotarget; 2017 Jan; 8(2):3441-3453. PubMed ID: 27966450
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA
Chen Z; Liu Z; Yang Y; Zhu Z; Liang R; Huang B; Wu D; Yang L; Lu H; Jin D; Li Q
Oncotarget; 2018 Jun; 9(42):26770-26786. PubMed ID: 29928484
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis.
Lu YB; Jiang Q; Yang MY; Zhou JX; Zhang Q
Oncotarget; 2017 Oct; 8(51):88804-88814. PubMed ID: 29179477
[TBL] [Abstract][Full Text] [Related]
19. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
20. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
